Scientific work

Doç. Dr. Berrin Yalçın

15 publications. The source of the information is stated next to each publication.

Back to profile

  1. Survival in Synchronous Versus Metachronous Bladder and Prostate Cancer

    Archivos Españoles de Urología, 2026

    DOI 10.56434/j.arch.esp.urol.20267905.93 PMID 42438875 Open-access full textSource: OpenAlex

  2. Qualitative Interferon-γ Release Assay for Predicting Response to BCG Instillations in Bladder Cancer

    Archivos Españoles de Urología, 2025

    DOI 10.56434/j.arch.esp.urol.20257808.133 PMID 41111372 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  3. Predictive Value of Systemic Inflammatory Markers in the Prognosis of Prostate Cancer with Variant Histology.

    Urology journal./Urology jornal., 2025

    DOI 10.22037/uj.v22i.8378 PMID 40684276 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  4. Survival in Synchronous Versus Metachronous Bladder & Prostate Cancer

    Research Square, 2025

    DOI 10.21203/rs.3.rs-7579205/v1 Open-access full textSource: ORCID

  5. Hemoglobin Level as a Prognostic Factor of Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer

    Istanbul Medical Journal, 2024

    DOI 10.4274/imj.galenos.2024.35902 1 citation (OpenAlex) Open-access full textSource: ORCID

  6. Qualitative Interferon-γ Release Assay for Predicting Response to BCG instillations in Bladder Cancer

    Research Square, 2024

    DOI 10.21203/rs.3.rs-4357424/v1 Open-access full textSource: ORCID

  7. Synchronous/Metachronous Bilateral Breast Cancer: a Long-Term Follow-up Single-Center Experience

    Indian Journal of Surgery, 2024

    DOI 10.1007/s12262-023-03965-z 1 citation (OpenAlex) Source: ORCID

  8. Discriminant Efficacy of mpMRI for Variant Pathology Associated with Prostate Adenocarcinoma.

    Urology journal./Urology jornal., 2023

    DOI 10.22037/uj.v20i.7468 PMID 36840448 Open-access full textSource: OpenAlex

  9. Radiotherapy for benign diseases in Turkey: a patterns of care survey of the Turkish Society for Radiation Oncology (TROD 05-002)

    Strahlentherapie und Onkologie, 2023

    DOI 10.1007/s00066-023-02154-x PMID 37796342 3 citations (Europe PMC) Source: OpenAlex

  10. Oncological outcomes for encapsulated papillary carcinoma of the breast: Multicentric study of Turkish Society for Radiation Oncology breast cancer study group (TROD 06–014 study)

    Asia-Pacific Journal of Clinical Oncology, 2023

    DOI 10.1111/ajco.13893 PMID 36464924 3 citations (Europe PMC) Open-access full textSource: ORCID

  11. Discriminant Efficacy of mpMRI for Variant Pathology Associated with Prostate Adenocarcinoma

    UROLOGY JOURNAL, 2023

    DOI 10.22037/uj.v20i.7468] Source: ORCID

  12. PRETREATMENT PROGNOSTIC NUTRITIONAL INDEX AND ALBUMIN/GLOBULIN RATIO ASSESSMENT AS A LARYNGEAL CANCER SURVIVAL PREDICTOR

    ACTA MEDICA MEDITERRANEA, 2023

    DOI 10.19193/0393-6384_2023_1_1 Source: ORCID

  13. Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study

    Critical Care, 2020

    DOI 10.1186/s13054-020-03215-8 PMID 32771054 44 citations (Europe PMC) Open-access full textSource: OpenAlex

  14. Comparation Between Radiotherapy Alone and Weekly Cisplatin and Concurrent Radiotherapy Application in Locally Advanced Cervix Cancer

    ISTANBUL MEDICAL JOURNAL, 2009

    Source: ORCID

  15. Evalutian of Prognostic Factors in Patients Recieved Adjuvant Radiotherapy After Mastectomy

    ISTANBUL MEDICAL JOURNAL, 2009

    Source: ORCID